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SulfasalazineAbstract Ameliorative effects ofMusa sapientum peel extract (MSPE) were studied on Acetic Acid
(AA)-induced colitis in rats. From a dose response study, the effective and yet, safe for the treat-
ment of AA-induced colitis in rats was determined, and also, a further study was carried out to
determine the effective fraction(s) of MSPE that will be useful in the treatment of AA induced colitis
in rats. Colitis was induced with 0.2 ml of 6% acetic acid through a lower abdominal laparotomy.
Treatment with graded doses of methanolic extract of dried peel of Musa sapientum (MS) (50, 100
and 200 mg/kg) for 7 days in AA induced colitis in rats showed 50 mg/kg as an optimal effective
dose for the healing of AA induced colitis in rats. This dose (50 mg/kg) was further studied with
fractions of MSPE in comparison to a standard drug (sulfasalazine) of the same dose (50 mg/kg)
on AA induced colitis in rats for 18 days. Colitis was assessed using stool consistency, macroscopic
gross score and histological studies. Normal stool consistency was seen early in treated animals as
compared with control; MS peel (crude extracts and fractions) significantly reduced macroscopic
and histologic colon tissue damage in a manner similar to that of sulfasalazine. The results from
these findings suggests that MSPE fractions of ethyl acetate and methanol may be effective in reduc-
ing both macroscopic and histological damage in a manner similar to sulfasalazine, and that it may
be helpful in the treatment of colitis.
 2016 The Egyptian German Society for Zoology Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Ulcerative colitis is a form of colitis which presents with char-
acteristic ulcers, or open sores (Ahmad et al., 2014) as a result
of chronic inflammation of the bowel, its cause is unknown but
it exhibits a clinical course with remission and exacerbations(Sellin and Pasricha, 2006; Podolsky and Fiocchi, 2000;
Podolsky, 1991). It is characterized by abdominal pain, rectal
bleeding and diarrhea and it primarily affects the colon and
rectum (Podolsky, 1991) with an incidence of 1–20 cases per
100,000 persons in a year, and a prevalence of 8–246 per
100,000 persons (Danese and Fiocci, 2011).
There are no effective therapies presently to cure the dis-
ease, although treatment regiments depend on reduction of
abnormal inflammation in the colon lining thereby reducing
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(Ahmad et al., 2014). However, Musa sapientum has been
shown to be medicinal and useful in the maintenance of bowel
functions (Goel and Sairam, 2002; Kumar et al., 2012).
Musa sapientum L. (Family: Musaceae), is commonly
known as ‘‘banana”. It is a perennial fruit tree that grows in
the tropics, with a height of about 5–9 m; it is made of a hard,
long pseudo-stem, and inflorescence with a reddish brown
bract. The fruits, leaves, peels, root and stalks of banana plants
are used orally or topically in the management of diarrhea,
dysentery, intestinal lesions, and hypoglycemia in local settings
(Stover and Simmonds, 1987).
Musa sapientum (MS) pulp used in in vitro work of animal
model, and limited human studies suggests that it may be ben-
eficial in the treatment of ulcerative colitis because of its phy-
tochemical content (Shah, 2007), MS peel however, has more
phytochemicals than its pulp (Someya et al., 2002; Kondo
et al., 2005; Sulaiman et al., 2011). Conventional therapies
for ulcerative colitis include amino salicylates, corticosteroids,
and immunosuppressive medications, these however do not
cure the condition but rather, they focus on producing and
maintaining remission (Podolsky, 2002; Forbes et al., 2004;
Baumaqart and Sandborn, 2007; Ahmad et al., 2014). Sul-
fasalazine and other 5-ASA drugs aim at scavenging reactive
oxygen species, but these synthetic drugs have been associated
with some complications and side effects on prolonged use;
this is why medicinal plants are being considered as alternative
therapies, especially those that have been found to possess
antioxidant properties.
The peels of Musa sapientum are natural and have been
found to possess antioxidant properties (Imam et al., 2011)
probably due to its flavonoidal and polyphenolic content, also,
Onasanwo et al. (2013) reported that people of the south-
western Nigeria, blend dried banana peel with yam flour to
make one of their main meals and that folk people say this
meal ameliorates gastric disorders. Moreover, studies have
reported the beneficial effects of antioxidants on experimental
colitis (Nosal’ova et al., 2000; Gulluoglu et al., 1999; Kaya
et al., 1999), antioxidants from plant sources like the Musa
sapientum peel are therefore being considered for the manage-
ment of colitis. This work was carried out to explore the ame-
liorative effect ofMusa sapientum peel extract on experimental
colitis in rats.
Materials and methods
Chemicals and reagents
Methanol, n-hexane, ethyl-acetate, ketamine, xylazine, acetic
acid, tween 20 and sulfasalazine.
Plant materials and extraction
Fresh peels (2.0 kg) of Musa sapientum (MS) were collected,
air-dried during harmattan (between November and Decem-
ber) and authenticated at Forestry Research Institute of Nige-
ria (FRIN), Ibadan, Nigeria, where the Voucher Specimen No:
109540 was deposited. The dried peels of MS were milled to
make a coarse powder. A part was refluxed with 90% metha-
nol to get the crude extract and the other part was fractionally
extracted with 100% n-hexane, ethyl acetate and methanolconsecutively. MS peel was fractionated in order to easily iden-
tify the part(s) containing the active components through
properties of the solvents used to carry out the extraction.
Animals
Albino rats of the Wistar strain weighing between 150 and
180 g were used for the experiment. The animals were acclima-
tized for two weeks and kept under standard conditions (370c)
in the Animal facility of the College of Medicine, University of
Ibadan, with food and water made accessible freely.
Experimental design
This experiment had an initial dose response study in which
rats were divided into four groups. Group 1 received the vehi-
cle (distilled water and 0.25 Tween 20); group 2 received
50 mg/kg of MS peel extract; group 3 received 100 mg/kg of
MS peel extract; and group 4 received 200 mg/kg of MS peel
extract orally once daily for 7 days post induction of colitis.
A further study was carried out thereafter, with extracts of
MS fractions on acetic acid-induced colitis in which rats were
divided into five groups. The dosage that presented with no
obvious side effect (50 mg/kg) of the three dosages (50, 100
and 200 mg/kg) and still showed healing potential in the initial
study was selected as the effective dose. Group 1 received the
vehicle (distilled water and 0.25 Tween 20) only; group II
received 50 mg/kg n-hexane fraction of the extract; group III
received 50 mg/kg ethyl acetate fraction of the extract; group
IV received 50 mg/kg methanol fraction of the extract; group
V received a standard drug (Sulfasalazine, 50 mg/kg) orally
once daily for 18 days post induction of colitis.
Induction of colitis
Rats were deprived of food for 18 h before colitis induction,
they were anesthetized with an intramuscular injection of 5%
ketamine (35.0 mg/kg) and 2% xylazine (5.0 mg/kg) and the
colon was approached through a ventral midline incision as
earlier described (Eyarefe and Amid, 2010; Uchida and
Mogami, 2005). The colon was exteriorized, clipped with an
eye forceps of 8 mm eye diameter, and 0.2 ml of 6% acetic acid
solution was injected into the colon lumen at the area limited
by the eye forceps, and the solution was withdrawn after 45 s
with the same injection syringe and needle. The colon was
returned into the abdominal cavity and the laparotomy inci-
sion was closed. Acetic acid model of colitis is an easy and
common method which has some resemblance to acute intesti-
nal inflammation in humans (Fabia et al., 1992).
Treatment schedules
Treatment commenced on the 3rd day of colitis induction and
it continued for 7 days by oral administration of graded doses
of the crude methanol extract of MS peel (50, 100, and
200 mg/kg) for the initial dose response study, this was done
to test the efficacy and dosage of MS peel extract that will
attenuate AA-induced colitis in experimental rats. Also, in
the further study, treatment commenced on the 3rd day of
colitis induction and it continued till 21st day by oral adminis-
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Sulfasalazine (50 mg/kg), once daily to appropriate animal
groups.
Assessment of colitis formation
In the initial dose response study, rats from each group were
sacrificed on the 3rd, 7th and 10th day of colitis induction
and also, in the further study on the 3rd, 7th, 14th and 21st
day of colitis induction. Colons were removed, cleared of fecal
content by rinsing in normal saline, analyzed macroscopically
and thereafter, fixed in 10% formalin for histological
assessment.
Stool consistency scoring
To assess the extent of colitis, stool consistency and occult
blood in the stool was monitored and scored daily
(Masonobi et al., 2002), with slight modifications as follows:
0-(normal/negative hemoccult), 1-(soft but still formed/
positive hemoccult), 2-(very soft/blood traces in stool visible),
3-(diarrhea/rectal bleeding).
Macroscopic scoring of colitis
Colon of animals were removed, cut longitudinally and slightly
cleaned in normal saline to remove fecal residues. Macroscopic
inflammation scores were assigned based on the grading scale
(Morris et al., 1989), ranging from 0 to 4 as follows: 0-(no
ulcer), 1-(mucosal erythema only), 2-(Mild mucosal edema,
bleeding ulcers or erosions), 3-(Moderate mucosal, bleedingTable 1 Stool consistency for initial dose response study.
Groups Dose Scoring
Day1 Day
Control Water 0.11 ± 0.11 0.33
50 mg/kg of MS extract 50 mg/kg 0.22 ± 0.15 0.11
100 mg/kg of MS extract 100 mg/kg 0.56 ± 0.18 0.78
200 mg/kg of MS extract 200 mg/kg 0.22 ± 0.15 1.22
Values were expressed as mean ± S.E.M of 5 rats.
*** p< 0.001.
* p< 0.05.
** p< 0.01.
Table 2 Stool consistency for further study.
Groups Dose Scoring
Day7 Day9 Day
Control Water 0.83 ± 0.24 1.58 ± 0.36 2.87
N-hFMS 50 mg/kg 1.75 ± 0.22 0.50 ± 0.19 1.63
EAFMS 50 mg/kg 0.75 ± 0.22 1.33 ± 0.23 0.88
MFMS 50 mg/kg 1.83 ± 0.21* 1.25 ± 0.18* 2.25
Sulfasalazine 50 mg/kg 1.00 ± 0.25* 0.58 ± 0.23* 1.00
Values were expressed as mean ± S.E.M of 5 rats.
* p< 0.05.
** p< 0.01.
*** p< 0.001.ulcers or erosions), 4-(Severe ulcerations, erosions, edema, tis-
sue necrosis and perforations).
Histological studies
Colonic segments fixed in 10% formalin were embedded in
paraffin and cut into sections, this was then de-paraffinized
with xylene, hydrated and stained with hematoxylin and eosin.
Stained sections were assessed for inflammatory changes.
Statistical analysis
Analysis of data was performed using a statistical software-
graph pad prism (version 5.0). Results were expressed as
mean ± S.E.M, statistical significance was assessed using
one-way analysis of variance (ANOVA) followed by
Newman-Keuls multiple comparison test. Differences were
considered significant at *P< 0.05, **P< 0.01 and
***P< 0.001.Results
Stool consistency assessment
The stool consistency results as seen in Tables 1 and 2 showed
that there were relapses in the stool consistency of all the
groups in both the dose response and further study. Normal
stool consistency was later established and maintained till
the end of the experiment.2 Day3 Day5 Day6
± 0.17 0.44 ± 0.18 0.33 ± 0.21 0.17 ± 0.17
± 0.11 0.33 ± 0.17 1.50 ± 0.34* 1.50 ± 0.34*
± 0.15 0.56 ± 0.34 0.67 ± 0.21 1.50 ± 0.50*
± 0.28** 1.44 ± 0.18* 0.83 ± 0.17 1.17 ± 0.17*
11 Day12 Day13 Day14
± 0.13 2.63 ± 0.38* 2.63 ± 0.38 1.88 ± 0.23
± 0.42** 1.38 ± 0.42* 1.25 ± 0.37* 1.38 ± 0.38
± 0.23*** 0.88 ± 0.23** 0.38 ± 0.18*** 0.0 ± 0.0***
± 0.31 1.50 ± 0.46* 1.38 ± 0.46* 0.88 ± 0.40*
± 0.19*** 1.25 ± 0.16 0.50 ± 0.27*** 0.13 ± 0.13***
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MSPE significantly reduced mean gross score of macroscopic
colon morphology on day 7 in the 50, 100 and 200 mg/kg trea-
ted groups of the dose response and further study, significant
reduction was noticed in colon macroscopic gross score on
day 7 in ethyl acetate, methanol fraction of MSPE and sul-
fasalazine treated groups when compared with control as
shown in Tables 3 and 4.
Histological assessment
Histological studies as seen in Plates. 1 and 2 show lymphocyte
infiltration, edematous sub-mucosa and transmural inflamma-
tion at days 3, 7 and day 10 in all the groups for the initial dose
response study. In the further study, lymphocyte infiltration of
the mucosa was observed at days 3, 7, in all the groups but as
at day 14, recovery had started in n-hexane, ethyl acetate,
methanol MSPE fraction-treated groups, and sulfasalazine-Table 3 Mean macroscopic score of rats’ colon at different days in
Treatment Scoring
Day3 Day7
Control 3.33 ± 0.333 2.33 ±
50 mg/kg of MS extract 3.33 ± 0.333 0.67 ±
100 mg/kg of MS extract 3.67 ± 0.333 0.67 ±
200 mg/kg of MS extract 3.33 ± 0.333 0.67 ±
Values were expressed as mean ± S.E.M of 5 rats.
*** p< 0.001.
* p< 0.05.
** p< 0.01.
Table 4 Mean macroscopic score of rats’ colon at different days in
Groups Dose Scoring
Day3 Day7
Control Water 3.50 ± 0.289 1.75 ± 0.25
N-hFMS 50 mg/kg 3.25 ± 0.250 1.25 ± 0.25
EAFMS 50 mg/kg 3.75 ± 0.250 0.50 ± 0.28
MFMS 50 mg/kg 3.50 ± 0.289 0.00 ± 0.00
Sulfasalazine 50 mg/kg 3.50 ± 0.289 0.00 ± 0.00
Values were expressed as mean ± S.E.M of 5 rats.
* p< 0.01
** p< 0.05.
*** p< 0.001.treated group. By day 21, relatively normal structure with
intact mucosa and submucosa was seen in methanol, ethyl
acetate fraction treated, and sulfasalazine-treated groups as
compared with control group in which inflammation was still
evident.
Discussion
In this study, colitis was induced with acetic acid and this
resulted in a severe, deep ulcer on a particular spot of the colon
with high infiltration of inflammatory aggregates, and diarrhea
was evident in all the rats after induction of colitis. These may
be due to the damaging effects of AA on the colonic mucosa,
as well as alterations in the functions of the epithelium either
by the mast cells or their by-products. Such alterations in the
intestinal barrier function by mast cells and their products dur-
ing experimental colitis were reported by Stein et al. (1998).
Relapses observed in the stool consistency of all the groups
in both the dose response and further study is a common find-colitis for the initial dose-response study.
Day7 Gross Day10
0.333 1.67 ± 0.333
0.333* 0.67 ± 0.333
0.333* 0.33 ± 0.333
0.33** 1.00 ± 0.577
colitis for the further study.
Day7 Gross Day14 Day21
0 0.25 ± 0.250 0.00 ± 0.000
0 0.00 ± 0.000 0.00 ± 0.000
9** 0.00 ± 0.000 0.00 ± 0.000
0*** 0.00 ± 0.000 0.00 ± 0.000
0*** 0.00 ± 0.000 0.00 ± 0.000
Control 50mg/kg MS 100mg/kg MS 200mg/kg MS
Day 3 
Day 7 
Day 10
Plates. 1 Photomicrographs from colon sections of untreated (control) rats and those treated with 50, 100 and 200 mg.kg of crude
extracts of Musa sapientum peel extract before induction of colitis by acetic acid. Tissues were harvested on days 3, 7 and 10 after colitis
induction. Arrows show different levels of lymphocyte infiltration of the mucosa, hemorrhage and edema.
N-hexane fraction Ethyl-Acetate fraction Methanol fraction Sulfasalazine Control
Day 3 
Day 7 
Day 14
Day 21
Plates. 2 Photomicrographs from colon sections of untreated (control) rats and those N-hexane, Ethyl acetate and Methanol fractions
of Musa sapientum as well as Sulfasalazine (standard drug) before induction of colitis by acetic acid. Tissues were harvested on days 3, 7
and 14 and 21 days after colitis induction. In the slides where there were no arrows, no signs of lymphocyte infiltration of the mucosa,
hemorrhage and edema were seen.
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ever, observed and maintained earlier in treated groups till
the end of the experiment, this may be due to the fact that only
a little portion of the colon was affected and also, probably
due to the effects of MSPE administration. MS pulp have been
reported to possess antidiarrheal properties (Khare, 2007;
Ghani, 2003), intestinal transit period may have increased in
the treated groups thus, providing more time for absorption.
Similar increased transit period in mice was reported by
Hossain et al. (2011) when they administered 100 and
200 mg/kg MS.
MSPE significantly reduced mean gross score of macro-
scopic colon morphology in treated groups of the dose
response and further study; methanol and ethyl acetate frac-
tions of MSPE showed similar effects as sulfasalazine. This
may be attributed to MSPE and its fractions on mucosal
defensive factors as Sanyal et al. (1963) and Kumar et al.
(2012) reported the antiulcer effect of banana in pylorus liga-
tion and AA induced model of ulcer in rats respectively, this
they attributed to its predominating effect on mucosal defense
factors including enhanced cell proliferation and antioxidants
and reducing free radicals levels.
Photomicrographs of the histological studies showed that
inflammation, ulcer and edema reduced earlier in methanol,
ethyl acetate and n-hexane fraction of MS peel-treated groups,
and sulfasalazine treated group. Full recovery was noticed
earlier in the methanol and ethyl acetate fraction treated
groups in a similar manner to sulfasalazine treated group, this
was evident by an intact mucosa which may be due to MSPE’s
antioxidant activity. MS has been found with antioxidant
activity that gives it ability to scavenge free radicals and reduce
inflammation (Imam et al., 2011).
MSPE may have also acted by inhibiting autacoids and
prostaglandins, thereby reducing motility and hence, increas-
ing intestinal transit period, leading to an increase in absorp-
tion of water and electrolytes in the colon (Lewis et al.,
1999). Also, its flavonoid, serotonin and noradrenaline con-
tents may have accorded it antidiarrheal and antioxidant
potential (Kongkachuichai et al., 2010; Rabbani et al., 2001)
through vasoconstriction and free radical scavenging. In con-
clusion, these findings showed that MS peel extract fractions
of ethyl acetate and methanol may be effective in reducing
both macroscopic and histological damage in a manner similar
to the reference drug-sulfasalazine, and that it may be helpful
in the treatment of colitis although its major protective compo-
nents may be present in all the fractions; methanol, ethyl acet-
ate and n-hexane of the extract. It is however obvious, that
further studies would be required to identify its active compo-
nents, the exact mechanism of its action and also, biochemical
assays would be helpful in understanding the processes occur-
ring during healing.
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